Concepedia

Tanya Wroblewski

TW

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2017

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Tanya Wroblewski is an author at United States Food and Drug Administration specializing in adverse event reporting forms, pharmacology, and ventricular arrhythmia mechanisms.

Publications per year

2017–2020

3

Publications

3

Ibrutinib‐associated <i>Pneumocystis jirovecii</i> pneumonia

Regina Lee, Afrouz Nayernama, S. Christopher Jones et al. · American Journal of Hematology · 2017 · 25 citations

, , +12

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Connie Cheng, Daniel Woronow, Afrouz Nayernama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

, , +16

FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease

Bellinda L. King‐Kallimanis, Tanya Wroblewski, Virginia E. Kwitkowski et al. · Quality of Life Research · 2020 · 22 citations

, , +14

1–3 of 3